VOXAR 3D ENTERPRISE WITH CARDIAMETRIX

K061326 · Barcoview Mis Edinburgh · LLZ · May 25, 2006 · Radiology

Device Facts

• Record ID: K061326
• Device Name: VOXAR 3D ENTERPRISE WITH CARDIAMETRIX
• Applicant: Barcoview Mis Edinburgh
• Product Code: LLZ · Radiology
• Decision Date: May 25, 2006
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 892.2050
• Device Class: Class 2
• Attributes: Software as a Medical Device, 3rd-Party Reviewed

Intended Use

The Voxar 3D product family is a suite of products that is intended to provide tools for the reading and review of a DICOM compliant series of medical images which can be interpreted as representing a volume of data. These tools are meant for the use of trained medical Imaging professionals to aid in their reading and review of such data.

Device Story

Voxar 3D Enterprise with CardiaMatrix is a software suite for DICOM medical image review and analysis. Inputs include tomographic image data (CT, PET, angiography). The device provides 2D/3D visualization tools including MPRs (orthogonal, oblique, curved, slab), MIP, MinIP, volume rendering, and endoscopic review. It features segmentation, boundary detection, and path definition for tubular structures. Specialized clinical modules provide directed workflows for colon screening, vessel analysis, coronary analysis, and functional cardiac analysis. Computer-aided detection algorithms highlight potential structures of interest. Used by trained medical imaging professionals in clinical settings to assist in diagnosis and treatment planning. Output consists of processed images, measurements, and reports, aiding clinicians in evaluating anatomical structures and disease states.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Software-based medical image processing suite. Functions include 2D/3D visualization, segmentation, and computer-aided detection. Operates on DICOM-compliant image data. Connectivity via standard medical imaging networks. No specific hardware materials or energy sources defined as it is a software application.

Indications for Use

Indicated for trained medical imaging professionals to aid in reading/reviewing DICOM medical image volumes. Includes specialized applications for colon screening (polyps/tumors), vessel analysis (occlusive/aneurysmal disease, stent evaluation), coronary analysis (occlusive/aneurysmal disease), and functional cardiac analysis.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Submission Summary (Full Text)

{0}------------------------------------------------

# DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an image of an eagle with its wings spread.

Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850

MAY 2 5 2006

BarcoView MIS Edinburgh c/o Mr. Jeff D. Rongero Senior Project Engineer Underwriters Laboratories, Inc. 12 Laboratory Drive P.O. Box 13995 RESEARCH TRIANGLE PARK NC 27709-3995

Re: K061326

Trade/Device Name: Voxar 3D Enterprise with CardiaMetrix Regulation Number: 21 CFR \$892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: May 10, 2006 Received: May 10, 2006

Dear Mr. Rongero:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Image /page/0/Picture/10 description: The image is a black and white circular logo. The logo has the text "1906-2006 FDA Centennial" arranged in a circular fashion. The letters "FDA" are in the center of the logo in a large, bold font. There are three stars below the word "Centennial".

Preventing and Promoting Public Health

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|-----------------|----------------------------------|--------------|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | | 240-276-0100 |

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications For Use

#### Applicant:

BarcoView MIS Edinburgh, Bonnington Bond, 2 Anderson Place, Edinburgh, EH6 5NP, UK

510(k) Number (if known): Unknown

K061326

### Device Name:

Voxar 3D Enterprise with CardiaMatrix

#### Indications For Use:

The Voxar 3D product family is a suite of products that is intended to provide tools for the reading and review of a DICOM compliant series of medical images which can be interpreted as representing a volume of data. These tools are meant for the use of trained medical Imaging professionals to aid in their reading and review of such data.

The Voxar 3D product family provides several levels of functionality:

- Basic analysis tools used on a daily basis, such as 2D review, orthogonal Multi Planar Reconstructions ● (MPRs), oblique MPRs, curved MPRs, slab MPRs, slab MPRs, AvelP, MIP, MinIP, measurements, annotations, reporting, and distribution.
- Tools for in-depth analysis, such as regional segmentation of anatomical structures within the image data, . endoscopic review, color volume rendering of finite thickness data cross-sections, 3D review of data volumes, path definition through vescular and other tubular structures, boundary detection, and PET image analysis.
- Specialist tools and workflow enhancements for specific clinical applications which provide directed workflows, . custom User Interfaces, and special measurement and reporting functions optimized for the specific clinical applications. Also included are computer-sided detection signithms which are the user on possible structures of interest. Specialized dinical applications include:
- Colon Screening (which Is intended for the screening of patients for colonic polyps, turnours and other o lesions using tomographic Colonography),
- Vessel Analysis (which is intended for the qualitative and quantitative analysis of tomographic o anglographic studies to evaluate occusive and aneurismal diseases and the effectiveness of stents and stent grafts)
- Coronary analysis (which is Intended for the qualitative and quantitative analysis of coronary 0 arteries to evaluate occlusive and aneurismal disease).
- Functional cardiac analysis (which is intended to evaluate the functional characteristics of the heart), ರ

Prescription Use (21 CFR 801.109) OR

Over-The counter Use _

IR LEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE (ENFEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Rante Pales's

(Division Sign-Off) Division of Reprodu and Radiological D 510(k) Number

510K Submission Page C1